Histoindex Pte. Ltd.

Aug 10, 2025

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

May 01, 2025

HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion

Mar 17, 2025

A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT(TM)

Jan 24, 2021

HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC)

Dec 14, 2020

HistoIndex and Consortium Partners Awarded S$1.2M for the Development of AI-based Diagnostics Tool in the Identification of High-Risk Nonalcoholic Fatty Liver Disease Population